GNPX — Genprex, Inc.
Price · 2024-08-26 → 2026-08-21
499 daily closes shownAnonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2018-03-29.
Performance
Technicals
Others in Healthcare
Insider transactions (Form 4)
| date | insider | what | shares | price | value |
|---|---|---|---|---|---|
| 2026-04-14 | LONGNECKER BRENT M Director | Open-market sale | 10 | 1.23 | 12 |
| 2026-04-14 | LONGNECKER BRENT M Director | Open-market sale | 8 | 1.23 | 10 |
| 2026-02-27 | Confer Ryan M. President, CEO and CFO | Shares withheld for tax | 9.3K | 2.00 | 18.7K |
| 2026-02-27 | Berger Mark Stanley Chief Medical Officer | Shares withheld for tax | 7.2K | 2.00 | 14.3K |
| 2025-12-22 | Berger Mark Stanley Chief Medical Officer | Grant or award | 28.5K | 0.00 | 0 |
| 2025-12-22 | Confer Ryan M. President, CEO and CFO | Grant or award | 45.0K | 0.00 | 0 |
| 2025-12-22 | LONGNECKER BRENT M Director | Grant or award | 9.0K | 0.00 | 0 |
| 2025-12-22 | Moreno Toscano Jose Antonio Director | Grant or award | 9.0K | 0.00 | 0 |
| 2025-12-22 | Wilson William R Jr. Director | Grant or award | 9.0K | 0.00 | 0 |
| 2025-06-30 | Confer Ryan M. President, CEO and CFO | Shares withheld for tax | 5.8K | 0.23 | 1.3K |
Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →
Largest institutional holders
| manager | value | shares |
|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | 60.4K | 33.4K |
| MANCHESTER FINANCIAL INC | 36.2K | 20.0K |
| Mayflower Financial Advisors, LLC | 36.2K | 20.0K |
| VANGUARD CAPITAL MANAGEMENT LLC | 10.8K | 6.0K |
| JONES FINANCIAL COMPANIES LLLP | 3.8K | 2.1K |
| CITIGROUP INC | 3.7K | 2.0K |
| Cheviot Value Management, LLC | 1.8K | 1.0K |
| Sound Income Strategies, LLC | 1.6K | 1.0K |
| OSAIC HOLDINGS, INC. | 417 | 232 |
| Bernard Wealth Management Corp. | 362 | 200 |
13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →
Latest SEC filings
| form | filed | period | |
|---|---|---|---|
| 10-Q | 2026-08-14 | 2026-06-30 | on EDGAR ↗ |
| 8-K | 2026-08-05 | 2026-08-04 | on EDGAR ↗ |
| 8-K | 2026-08-03 | 2026-08-03 | on EDGAR ↗ |
| 8-K | 2026-07-30 | 2026-07-29 | on EDGAR ↗ |
| 8-K | 2026-07-14 | 2026-07-13 | on EDGAR ↗ |
| S-8 | 2026-06-26 | — | on EDGAR ↗ |
| 8-K | 2026-06-22 | 2026-06-22 | on EDGAR ↗ |
| 8-K | 2026-06-18 | 2026-06-18 | on EDGAR ↗ |
Short selling
This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →
Recent headlines
- Genprex, Inc. (GNPX) filed form 8-K · 2026-08-18 · SEC EDGAR
- Genprex Selects Leading Clinical and Commercial Contract Development and Manufacturing Organization for Manufacturing Scale Up of Diabetes Gene Therapy · 2026-08-18
- Genprex, Inc. (GNPX) filed form 10-Q · 2026-08-14 · SEC EDGAR
Ask the AI about GNPX
The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.
Everything on this page is live in the terminal.
Charts, filings, insider flow and the AI — open without an account.
Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →